0001013762-12-000875.txt : 20120417 0001013762-12-000875.hdr.sgml : 20120417 20120417135907 ACCESSION NUMBER: 0001013762-12-000875 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20120417 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20120417 DATE AS OF CHANGE: 20120417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medefile International, Inc. CENTRAL INDEX KEY: 0000842013 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 850368333 STATE OF INCORPORATION: NV FISCAL YEAR END: 0121 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 033-25126-D FILM NUMBER: 12763346 BUSINESS ADDRESS: STREET 1: 2 RIDGEDALE AVENUE STREET 2: SUITE 217 CITY: CEDAR KNOLLS STATE: NJ ZIP: 07927 BUSINESS PHONE: (973) 993-8001 MAIL ADDRESS: STREET 1: 2 RIDGEDALE AVENUE STREET 2: SUITE 217 CITY: CEDAR KNOLLS STATE: NJ ZIP: 07927 FORMER COMPANY: FORMER CONFORMED NAME: OMNIMED INTERNATIONAL, INC. DATE OF NAME CHANGE: 20051122 FORMER COMPANY: FORMER CONFORMED NAME: BIO SOLUTIONS INTERNATIONAL INC DATE OF NAME CHANGE: 20010214 FORMER COMPANY: FORMER CONFORMED NAME: SEPTIMA ENTERPRISES INC DATE OF NAME CHANGE: 19920703 8-K 1 form8k.htm MEDEFILE INTERNATIONAL, INC. FORM 8-K form8k.htm
 UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
____________________________________________________________
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
___________________________________________________________________
 
Date of Report (Date of earliest event reported):  April 17, 2012
 
MedeFile International, Inc.
(Exact name of registrant as specified in its charter)
 
Nevada
033-25126 D
85-0368333
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
 
 
301 Yamato Road
Suite 1200
Boca Raton, FL
33431
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code: (561) 912-3393

Copies to:
Richard A. Friedman, Esq.
Jeff Cahlon, Esq.
Sichenzia Ross Friedman Ference LLP
61 Broadway, 32 nd Floor
New York, New York 10006
Telephone: (212) 930-9700

 
(Former name or former address, if changed since last report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
  o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
  o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
  o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
    o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 

 



 
Item 2.02 Results of Operations and Financial Condition.

On April 17, 2012, MedeFile International, Inc. (the “Company”) issued a press release announcing its financial results for the year ended December 31, 2011 and certain other information. A copy of the Company’s press release announcing these financial results and certain other information is attached hereto as Exhibit 99.1.
 
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing.
 
Item 9.01 Financial Statements and Exhibits.

Exhibit No.
 
Description
99.1
 
Press Release dated April 17, 2012.
 
 
 
 

 
 

SIGNATURES

 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
MEDEFILE INTERNATIONAL, INC.
 
       
Date: April 17, 2012
By:
/s/ Kevin Hauser
 
   
Kevin Hauser
 
   
Chief Executive Officer
 
       

 
 
 
 
 
 
 
EX-99.1 2 ex991.htm EXHIBIT 99.1 ex991.htm

 
MedeFile International Reports 2011 Yearend Financial Results
 
 
Revenues Increase 270% and Net Loss Declines 17% Year-Over-Year; CEO Comments on Tactical Marketing Strategy for Accelerating PHR Subscriber Growth
 
BOCA RATON, FL--(Marketwire -04/17/12)- MedeFile International, Inc. (OTCQB: MDFI.PK - News) (Pinksheets: MDFI.PK - News), a leader in Internet-enabled Personal Health Record (iPHR) management solutions, today announced its financial results for the 12 months ended December 31, 2011.
 
Financial Highlights:
 
·  
In 2011, revenues totaled $495,451, rising 270% over revenues of $133,869 reported for the prior year.
 
·  
Gross profit margin on revenues improved to 67% from 54% on a year-over-year basis.
 
·  
Net loss declined 17% to $2,079,374, or $0.00 per basic and fully diluted share in 2011, compared to $2,492,310, or $0.00 per basic and fully diluted share, reported for 2010.
 
·  
As of December 31, 2011, cash and accounts receivable totaled $198,790; working capital was $126,201 and total shareholders' equity was $164,045.
 
For more detailed information relating to the Company's yearend results, please refer to the financial statements included with this press release and the 10-K that was filed with the U.S. Securities and Exchange Commission yesterday, April 16, 2012.
 
Commenting on the results, Kevin Hauser, President and CEO of MedeFile, noted, "Last year proved to be a defining year for MedeFile in numerous ways. Mid-year, we determined that our strategy to drive consumer adoption of the MedeFile iPHR solution through telemarketing campaigns and televised infomercials were less than optimal methods of accelerating individual membership growth, and the cost per subscriber acquisition was high -- particularly when compared to the margins we can realize through our wholesale channels."
 
"Consequently, we chose to adopt a more tactical approach to our global marketing efforts, electing to focus solely on pursuing major wholesale opportunities with large medical practice groups and institutions, insurance companies, trade unions, affinity groups and other notable organizations capable of enrolling thousands of MedeFile subscribers onto our iPHR platform simultaneously. Although this route to success has required significant time, patience and certain enhancements to our day-to-day systems of operation on our part, our efforts over the past six to eight months have begun to yield tangible results -- particularly over the past several weeks," Hauser said.
 
During the month of March, MedeFile announced the commencement of a 90-day pilot program with Promise Healthcare, a leading national long-term acute hospital company employing nearly 3,000 people -- all of whom MedeFile anticipates will enroll as MedeFile subscribers, presuming a successful pilot. In addition, the Company reported that it has formed a new joint venture named MedeFile Iberia, S.L., which will be based in Madrid. The joint venture marks MedeFile's first major international expansion initiative which will focus on marketing and distributing the Company's iPHR solution to consumers, healthcare institutions, government agencies and insurance companies in Spain. MedeFile also announced that it has welcomed Medical Specialists of the Palm Beaches to its Quality of Care Program, providing for MSPB's 75+ physicians to encourage their universal base of more than 200,000 patients to subscribe to MedeFile.
 
"These recent positive developments are an indication that our decision to concentrate on wholesale opportunities has been the right one," stated Hauser. "Moving forward, we are in discussions and negotiations with numerous other companies and organizations of like size and scope as those we've already detailed; and, thanks to impressive cost-saving data being released by several leading U.S. corporations that have integrated custom PHRs into their employee benefits platforms, MedeFile has been responding to an increasing number of Requests for Proposals from large, self-insured employers seeking to do the same."
 
In closing, Hauser stated, "Although the journey, thus far, has been fraught with challenges and hurdles to success, our team remains absolutely dedicated to and intent on achieving our mission to establish MedeFile as the world's preferred Personal Health Record management solution."
 
 
 
 
1

 
 
 
MEDEFILE INTERNATIONAL, INC.
BALANCE SHEETS
(Audited)
 
 
                            
           
                                              
 
December 31,
   
December 31,
 
Assets                                                      
 
2011
   
2010
 
             
Current assets
           
Cash      
  $ 198,173 $       499,652  
Accounts receivable, net 
    617       2,468  
Inventory  
    53,925       22,184  
Merchant services reserve   
    62,530       6,173  
Prepaid insurance  
    1,055       -  
                 
Total current assets         
    316,300       530,477  
Website development, net of accumulated
               
amortization                           
    26,227       47,210  
Furniture and equipment, net of
               
accumulated depreciation     
    10,278       20,364  
Intangibles              
    1,339       1,339  
                 
Total assets        
  $ 354,144     $ 599,390  
                 
Liabilities and Stockholders' Equity
               
Accounts payable and accrued liabilities 
  $ 180,244     $ 310,325  
Cash overdraft    
    -       6,928  
Deferred revenues      
    9,855       9,575  
                 
Total Current Liabilities        
    190,099       326,828  
                 
Stockholders' Equity
               
Preferred stock, $.0001 par value: 10,000
               
authorized, no shares issued and
               
outstanding                           
    -       -  
Common stock, $.0001 par value:
               
5,000,000,000 authorized; 3,958,258,852
               
and 3,450,021,410 shares issued and
               
outstanding on December 31, 2011 and
               
2010, respectively          
    395,826       345,002  
Common stock payable           
    24,000       -  
Additional paid in capital         
    17,986,149       16,090,116  
Accumulated deficit        
    (18,241,930 )       (16,162,556 )
                 
Total stockholders' equity    
    164,045       272,562  
                 
Total liability and stockholders'
               
equity        
  $ 354,144     $ 599,390  
                 


 
 
2

 

 
MEDEFILE INTERNATIONAL, INC.
STATEMENT OF OPERATIONS
FOR THE YEARS ENDED DECEMEBER 31, 2010 AND 2011
 (Audited)
 
             
                                                          
  2011     2010  
Revenue
  $ 495,451     $ 133,869  
                 
Cost of goods sold
    163,630       61,610  
                 
Gross profit
    331,821       72,259  
                 
Operating expenses
               
Selling, general and administrative
               
expenses
    1,855,825       1,134,371  
Marketing expense
    524,301       170,488  
Depreciation and amortization expense
    31,069       29,911  
                 
Total operating expenses
    2,411,195       1,334,770  
                 
Loss from operations
    (2,079,374 )     (1,262,511 )
                 
Other income (expenses)
               
Interest expense - note payable
    -       (10,166 )
Interest expense - related party note
               
payable
    -       (1,219,633 )
                 
Total other income (expense)
    -       (1,229,799 )
                 
Loss before income tax
    (2,079,374 )     (2,492,310 )
Provision for income tax
    -       -  
                 
Net loss
  $ (2,079,374 )   $ (2,492,310 )
                 
Net loss per share: basic and diluted
  $ (0.00 )   $ (0.00 )
                 
Weighted average share outstanding basic and
               
diluted
    3,715,587,476        2,346,081,850  
 
 
 
3

 

 
 
About MedeFile International, Inc.
 
 
Headquartered in South Florida, MedeFile has developed and globally markets a proprietary, patient-centric, iPHR (Internet-enabled Personal Health Record) system for gathering, digitizing and organizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile's primary product is its web-based MedeFile solution, a highly secure system for gathering, maintaining, accessing and sharing personal medical records. Interoperable with most electronic medical record management systems marketed to the healthcare industry, the MedeFile solution is designed to gather all of its members' actual medical records and create a single, comprehensive Electronic Health Record (EHR) that is accessible 24 hours a day, seven days a week by the member and the member's authorized users on any web-enabled device (PC, cell phone, smartphone, e-reader) and portable MedeDrive unit. For more information about MedeFile and its annual subscription-based programs, please visit www.medefile.com. You can also follow the Company on Facebook!
 
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
 
With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.
 
Contact:
 
FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
 
Elite Financial Communications Group, LLC
 
Dodi B. Handy
 
President and CEO
 
Twitter: dodihandy
 
For Media:
 
Kathy Addison
 
COO
 
Twitter: kathyaddison
 
(407) 585-1080
 
Email Contact
 

 
 
 
4